Shares of Alivus Life Sciences came into focus after the company reported its Q3 FY26 results. In Q3, Alivus Life Sciences Limited reported a profit after tax (PAT) of Rs 1.50 billion (bn), up 9.7% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results